Summary
Tissue engineered grafts based on polymeric or acellular xenogeneric matrices have been widely studied, and found to have greater durability and functionality with growth potential and less immunogenicity than current bioprostheses. On the other hand, there are still several problems to be solved such as degradation control of biodegradable polymeric scaffolds and unwanted transfer of unknown animal related infectious diseases. In this chapter, our novel tissue processing of decellularization named PowerGraft by ultrahigh pressure treatment for safe tissue transplantation is reported. Porcine heart valves were isolated under sterile conditions and treated by cold isostatic pressing (CIP) at 4°C for disruption of donor cells. The cell debris was then washed out in PBS under microwave irradiation at 4°C. The tissues were completely cell free when they were treated by a CIP of 980 MPa (10,000 atm) for 10 min. There was no porcine endogeneous retrovirus (PERV) detected in the treated tissue. There were no significant changes in biomechanical properties of breaking strength and elastic modulus. From the in vitro incubation test, the tissues were disinfected when CIP was applied to the tissues contaminated by normal bacteria floras. The endothelial cells were well seeded on the acellular bioscaffold by the roller and circulation culture systems sequentially. This PowerGraft processing may provide a more durable and safe bioscaffold for tissue transplantation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bader A, Schilling T, Teebken OE, Brandes G, Herden T, Steinhoff G, Haverich A (1998) Tissue engineering of heart valves—human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg 14(3):279–84
Booth C, Korossis SA, Wilcox HE, Watterson KG, Kearney JN, Fisher J, Ingham E (2002) Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. Heart Valve Dis 11(4):457–62
Dohmen PM, Lembcke A, Hotz H, Kivelitz D, Konertz WF (2002) Ross operation with a tissue-engineered heart valve. Ann Thorac Surg 74(5): 1438–42
Elkins RC, Goldstein S, Hewitt CW, Walsh SP, Dawson PE, Ollerenshaw JD, Black KS, Clarke DR, O’brien MF (2001) Recellularization of heart valve grafts by a process of adaptive remodeling. Semin Thorac Cardiovasc Surg 13(4 Suppl 1):87–92
Hayashi R (2002) High pressure in bioscience and biotechnology: pure science encompassed in pursuit of value. Biochim Biophys Acta 1595(1–2):397–9
Hildebrand DK, Wu ZJ, Mayer JE Jr, Sacks MS (2004) Design and hydrodynamic evaluation of a novel pulsatile bioreactor for biologically active heart valves. Ann Biomed Eng 32(8): 1039–49
Laube HR, Matthaus M (2001) A new semi-automatic endothelial cell seeding technique for biological prosthetic heart valves. Int J Artif Organs 24(4):243–6
Magre S, Takeuchi Y, Bartosch B (2003) Xenotransplantation and pig endogenous retroviruses. Rev Med Virol 13(5):311–29
Schenke-Layland K, Opitz F, Gross M, Doring C, Halbhuber KJ, Schirrmeister F, Wahlers T, Stock UA (2003) Complete dynamic repopulation of decellularized heart valves by application of defined physical signals-an in vitro study. Cardiovasc Res 60(3):497–509
Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, Rieder E, Wolner E (2003) Early failure of the tissue engineered porcine heart valve SYNERGRAFT™ in pediatric patients. Euro J Cardiothorac Surg 23:1002–6
Teebken OE, Puschmann C, Aper T, Haverich A, Mertsching H (2003) Tissue-engineered bioprosthetic venous valve: a long-term study in sheep. Eur J Vasc Endovasc Surg 25(4):305–12
Zeltinger J, Landeen LK, Alexander HG, Kidd ID, Sibanda B (2001) Development and characterization of tissue-engineered aortic valves. Tissue Eng 7(1):9–22
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Tokyo
About this chapter
Cite this chapter
Fujisato, T. et al. (2005). Preparation and Recellularization of Tissue Engineered Bioscaffold for Heart Valve Replacement. In: Mori, H., Matsuda, H. (eds) Cardiovascular Regeneration Therapies Using Tissue Engineering Approaches. Springer, Tokyo. https://doi.org/10.1007/4-431-27378-6_7
Download citation
DOI: https://doi.org/10.1007/4-431-27378-6_7
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-23925-3
Online ISBN: 978-4-431-27378-3
eBook Packages: MedicineMedicine (R0)